Journament

Keyword Connections - severe acute respiratory syndrome coronavirus 2 Keywords

Connection Type	Connection
Journals	american journal of transplantation : official journal of the american society of transplantation and the american society of transplant surgeons emerging infectious diseases infectious diseases of poverty The Journal of the Association of Physicians of India american journal of kidney diseases : the official journal of the national kidney foundation journal of the royal society of medicine cell host & microbe sexual and reproductive health matters journal of experimental orthopaedics the lancet neurology the journal of dermatological treatment archives of academic emergency medicine pathogens and global health Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace emergency medicine practice
Research Groups	No Research Group Connected
Bibliographies	[1] Serial Interval of COVID-19 among Publicly Reported Confirmed Cases. [2] COVID-19: What implications for sexual and reproductive health and rights globally? [3] Should patients stop their biologic treatment during the COVID-19 pandemic. [4] Prevalence of Underlying Diseases in Hospitalized Patients with COVID-19: a Systematic Review and Meta-Analysis. [5] Emerging prophylaxis strategies against COVID-19. [6] Infection and Rapid Transmission of SARS-CoV-2 in Ferrets. [7] Calculated decisions: COVID-19 calculators during extreme resource-limited situations. [8] Doubling Time of the COVID-19 Epidemic by Province, China. [9] Earliest cases of coronavirus disease 2019 (COVID-19) identified in solid organ transplant recipients in the United States. [10] The Swiss approach to the COVID-19 outbreak. [11] The impact of the COVID-19 outbreak on Liver Transplantation programmes in Northern Italy. [12] Clusters of Coronavirus Disease in Communities, Japan, January-April 2020. [13] Impact of COVID-19 public health interventions on influenza incidence in Thailand. [14] COVID-19: the great unequaliser. [15] COVID-19 in India. [16] Uncertainty and COVID-19: how are we to respond? [17] The primary care response to COVID-19 in England's National Health Service. [18] Anatomising failure: there should be a statutory public inquiry into the UK Government's handling of COVID-19. [19] Serologic Detection of SARS-CoV-2 Infections in Hemodialysis Centers: A Multicenter Retrospective Study in Wuhan, China. [20] Neurological associations of COVID-19. [21] Clinical characteristics of four cancer patients with SARS-CoV-2 infection in Wuhan, China. [22] Clinical and Epidemiological Features of SARS-CoV-2 Patients in SARI Ward of a Tertiary Care Centre in New Delhi. [23] It is not 'business as usual' for orthopaedic surgeons in May 2020- the Austrian-German-Swiss experience. [24] Safety Considerations in the Laboratory Testing of Specimens Suspected or Known to Contain the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). [25] Possible Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in a Public Bath Center in Huai'an, Jiangsu Province, China. [26] Fear can be more harmful than the severe acute respiratory syndrome coronavirus 2 in controlling the corona virus disease 2019 epidemic [27] Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in Children and Adolescents: A Systematic Review. [28] Clinical presentation and initial management critically ill patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in Brescia, Italy. [29] Lack of Vertical Transmission of Severe Acute Respiratory Syndrome Coronavirus 2, China [30] Horizontal transmission of severe acute respiratory syndrome coronavirus 2 to a premature infant: multiple organ injury and association with markers of inflammation. [31] On the usefulness of point-of-care antibody tests for severe acute respiratory syndrome coronavirus 2 in community screening settings. [32] Analysis of adjunctive serological detection to nucleic acid test for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection diagnosis. [33] Clinical features, isolation, and complete genome sequence of severe acute respiratory syndrome coronavirus 2 from the first two patients in Vietnam. [34] The Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Epidemic in Zimbabwe: Quo Vadis? [35] Virucidal Efficacy of Different Oral Rinses Against Severe Acute Respiratory Syndrome Coronavirus 2 [36] Characterization of an Asymptomatic Cohort of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infected Individuals Outside of Wuhan, China [37] Sensitivity of Nasopharyngeal Swabs and Saliva for the Detection of Severe Acute Respiratory Syndrome Coronavirus 2 [38] In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) [39] Absence of Vaccine-enhanced Disease With Unexpected Positive Protection Against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by Inactivated Vaccine Given Within 3 Days of Virus Challenge in Syrian Hamster Model [40] Coinfection by Severe Acute Respiratory Syndrome Coronavirus 2 and Influenza A(H1N1)pdm09 Virus Enhances the Severity of Pneumonia in Golden Syrian Hamsters [41] Effect of High vs Low Doses of Chloroquine Diphosphate as Adjunctive Therapy for Patients Hospitalized With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection: A Randomized Clinical Trial [42] The Natural History and Transmission Potential of Asymptomatic Severe Acute Respiratory Syndrome Coronavirus 2 Infection [43] Impact of Severe Acute Respiratory Syndrome Coronavirus 2 Viral Load on Risk of Intubation and Mortality Among Hospitalized Patients With Coronavirus Disease 2019 [44] Hydroxychloroquine for Prevention of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection: Challenges to Trial Conduct During the Global Pandemic [45] Use of US Blood Donors for National Serosurveillance of Severe Acute Respiratory Syndrome Coronavirus 2 Antibodies: Basis for an Expanded National Donor Serosurveillance Program [46] Correlation Between Early Plasma Interleukin 37 Responses With Low Inflammatory Cytokine Levels and Benign Clinical Outcomes in Severe Acute Respiratory Syndrome Coronavirus 2 Infection [47] High Prevalence of Anti–Severe Acute Respiratory Syndrome Coronavirus 2 (Anti–SARS-CoV-2) Antibodies After the First Wave of Coronavirus Disease 2019 (COVID-19) in Kinshasa, Democratic Republic of the Congo: Results of a Cross-sectional Household-Based Survey [48] Chronic Asymptomatic Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in the Immunocompromised Patient: New Challenges and Urgent Needs [49] Sensitivity of Nasopharyngeal Swabs and Saliva for the Detection of Severe Acute Respiratory Syndrome Coronavirus 2 [50] In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) [51] Children and Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Transmission: A Step Closer to Better Understanding and Evidence-Based Interventions? [52] Poor Antibody Response After Two Doses of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccine in Transplant Recipients [53] Variants of Concern Are Overrepresented Among Postvaccination Breakthrough Infections of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in Washington State [54] Characterization of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection Clusters Based on Integrated Genomic Surveillance, Outbreak Analysis and Contact Tracing in an Urban Setting [55] Concomitant Marked Decline in Prevalence of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Other Respiratory Viruses Among Symptomatic Patients Following Public Health Interventions in Australia: Data from St Vincent’s Hospital and Associated Screening Clinics, Sydney, NSW [56] Extensive Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Transmission Associated With Low Mortality in Kinshasa, Democratic Republic of the Congo: For How Long? [57] Mental Health Indices of Intensive Care Unit and Emergency Room Frontliners during the Severe Acute Respiratory Syndrome Coronavirus 2 Pandemic in India [58] Striking lineage diversity of severe acute respiratory syndrome coronavirus 2 from non-human sources.